Jeremy Grantham Amgen Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $9.49 Million - $11.3 Million	-43,879 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $633,555 - $704,565	-2,700 Reduced 5.8%	43,879 $11.2 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $3.55 Million - $4.36 Million	-17,952 Reduced 27.82%	46,579 $11 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $206,113 - $273,362	1,131 Added 1.78%	64,531 $13.1 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $2.5 Million - $3.21 Million	-13,200 Reduced 17.23%	63,400 $15.3 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $9.65 Million - $11.6 Million	-55,400 Reduced 41.97%	76,600 $14.8 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $466,759 - $547,148	-2,800 Reduced 2.08%	132,000 $24.3 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.41 Million - $1.59 Million	-7,800 Reduced 5.47%	134,800 $25.6 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $142,720 - $166,600	800 Added 0.56%	142,600 $27.8 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $24.6 Million - $27.7 Million	132,500 Added 1424.73%	141,800 $29.4 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $398,520 - $447,624	2,400 Added 34.78%	9,300 $1.72 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $830,207 - $970,200	4,900 Added 245.0%	6,900 $1.18 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $33,758 - $37,718	-200 Reduced 9.09%	2,000 $348,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,200	2,200 $379,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.